Abstract. Certain components of apples have been shown to prevent cancer growth and impede cancer progression. We hypothesized that extracted apple polysaccharides (APs) might, therefore, have anticancer effects, through a mechanism involving the induction of apoptosis in cancer cells, partly via the NF-κB pathway. Two human colorectal cancer (CRC) cell lines, HT-29 and SW620, were exposed to different concentrations of APs (0.01, 0.1 or 1 mg/ml). Cell apoptosis was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay by flow cytometry and incorporation of 5'-bromodeoxyuridine (BrdU) into DNA to identify the proliferating cell fraction, using fluorescence microscopy in vitro. The protein levels of NF-κB/p65, I-κBα, pI-κBα, Bax, Bcl-xl and Bcl-2 were evaluated by western blotting. The target sites of APs on CRC cells were assessed by flow cytometry. At concentrations of 0.1 and 1 mg/ml, APs showed apoptosis-inducing effects, increased expressions of Bax, nuclear p65 and cytoplasmic pI-κBα, and decreased expressions of Bcl-2, Bcl-xl and cytoplasmic I-κBα. APs induced apoptosis by slightly activating the NF-κB pathway; the AP target site could be the Toll-like receptor 4 on the cell membrane. These results demonstrate the potential of APs as agents for clinical prevention and treatment of CRC.
Introduction
Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality, with approximately half a million deaths and over 1 million new cases estimated per year, mostly in western and well-developed countries (1, 2) . Dietary changes may prevent 70-80% of CRC cases (3, 4) . The most potent agents used for cancer prevention and treatment should be nontoxic, such as those that are naturally present in foods.
As is well known, regular consumption of fruits and vegetables is inversely associated with colorectal cancer risk. Apples have been identified as chemopreventive agents and are linked to a reduced risk of cancer (5, 6) . We therefore, observed the effect of apple polysaccharides (AP) on CRC cell apoptosis and investigated their anticancer mechanism.
The transcription factor NF-κB exists in almost all cell types, and is critically involved in the regulation of apoptosis (7) . The aim of the present study was to determine whether APs mediate an antitumor effect, and, if so, to investigate whether the relevant cell mechanism involved the NF-κB pathway.
Materials and methods
Reagents. Cytoplasmic and nuclear extracts were purchased from Pierce Biotechnology, Inc. (USA). Lipopolysaccharides (LPS) were obtained from Escherichia coli 055:B5 F8666-fluorescein isothiocyanate (FITC) conjugate, 5'-bromodeoxyuridine (BrdU) was from Sigma (St. Louis, MO).
Cell culture. HT-29 and SW620 cell lines as well as human intestinal epithelial cells (HIEC) were obtained from the American Type Culture Collection. The HT-29 and SW620 cell lines were separately cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS); HIEC were cultured in Dulbecco's modified Eagle's medium with 10% FBS and 0.2 U/ml insulin, with a mixture of antibiotics (100 U/ml penicillin G and 100 µg/ml streptomycin); all cells were incubated at 37˚C in an atmosphere of 95% oxygen and 5% CO 2 .
Preparation of AP. Apples were purchased from Sanyuan (Shaanxi, China). APs were extracted according to previously published methods (8) . Briefly, residues were separated from squeezed apple juice, boiled with ethanol to remove alcohol-soluble components, and then boiled with water to Flow cytometric analysis. The HT-29 and SW620 cells were grown to 5x10 4 in 6-well plates and cultured with AP at 0.01, 0.1 or 1 mg/ml for 48 h. Cells were harvested and washed in ice-cold PBS, and FITC Annexin V and propidium iodide (PI) were added. Apoptosis was analyzed by flow cytometry. All fluorescence and laser light scatter measurements were conducted with linear signal-processing electronics.
We then examined the effects of preincubation of CRC cells with AP on LPS-FITC binding. Different concentrations (0.01, 0.1 or 1 mg/ml) of AP were incubated with HT-29 and SW620 cells, in 5% CO 2 and 95% air for 60 min at 37˚C. A fixed concentration of LPS-FITC (10 µg/ml) was added and incubation continued for another 60 min. After incubation, cells were washed three times with PBS to remove non-conjugated FITC-LPS. Fluorescence intensity (FI) was determined by flow-cytometric analysis.
Protein extraction and western blot analysis. The CRC cells were cultured in 100-ml cell culture bottles with AP at 0.01, 0.1 or 1 mg/ml for 48 h. Cells were used for whole cell-free extracts and nuclear/cytoplasmic protein separation or stored at -80˚C for future use. Nuclear and cytoplasmic proteins were isolated with a buffer extraction system and centrifugation according to the manufacturer's recommended protocol. Protein concentrations were determined using BCA reagents with BSA as a standard. Equal amounts of proteins (40 µg) were separated by 12% SDS-PAGE and transferred electrophoretically to nitrocellulose membranes (Pall Corporation, Port Washington, NY, USA). The membranes were blocked with 5% non-fat dry milk in PBS Tween-20 (PBST) for 2 h at room temperature and subsequently incubated overnight at 4˚C with primary antibodies: rabbit anti-Bcl-2, Bcl-xl, I-κBα and pI-κBα (Bioworld Technology, Inc., USA) 1:500 dilution; rabbit anti-Bax (Abcam Co., Cambridge, UK) 1:1,000 dilution; and rabbit anti-p65 and anti-β-actin (Bioworld Technology, Inc.) 1:1200 dilution in 5% (w/v) BSA. After 3 washes with PBST, membranes were incubated with anti-rabbit secondary antibodies (1:7,000) for 2 h at room temperature. After three washes with PBST, signals were detected using the Gel Doc system (Bio-Rad). Immunofluorescence analysis. The HT-29 and SW620 cells were each grown in 24-well plates seeded with 1x10 5 cells/well and cultured with AP at 0.01, 0.1 or 1 mg/ml, for 24 h. After fixing and washing, cells were incubated for 1 h at 37˚C with rabbit antihuman NF-κB p65 antibody. Slides were washed 3 times with 0.05% Triton X-100-PBS solution, then incubated for 1 h at 37˚C with goat anti-rabbit IgG TRITC-conjugated secondary antibody. Cells were then washed with PBS and examined under a fluorescence microscope (magnification, x40).
Statistical analysis.
Results are expressed as the mean ± standard deviation (SD); different groups were compared using ANOVA tests. P<0.05 was considered to indicate statistically significant differences. .9995). Accordingly, the molecular weight of AP was 5,000-10,000 Da.
Results

AP inhibits proliferation of CRC.
To verify the effects of AP on cell-cycle progression, DNA synthesis was measured by assessing BrdU incorporation; labeled cell preparations were analyzed under a fluorescence microscope (Fig. 1) . Results showed proliferating cells (bright red nuclei) within the CRC cell preparation clearly visible under the fluorescence microscope; AP inhibited the growth of CRC cells at the concentrations of 0.1 and 1 mg/ml. (Fig. 2) showed that AP treatments at 0.1 or 1 mg/ml for 48 h increased Bax and decreased Bcl-2 and Bcl-xl expression. Apoptosis was then assessed by flow cytometry (Fig. 3) . At 0.1 and 1 mg/ml, APs triggered apoptosis of some CRC cells, but had no effect on HIEC.
AP induces apoptosis in CRC cells. Western blotting
Induction of apoptosis by APs correlates with the activation of NF-κB.
Western blotting showed that treatment with APs at 0.1 or 1 mg/ml for 48 h increased the expression of nuclear p65 and cytoplasmic pI-κBα, and decreased cytoplasmic I-κBα expression in HT-29 and SW620 cells, but had no effect on HIEC (Fig. 4) .
To determine whether APs could activate NF-κB, we used anti-NF-κB p65 antibody and fluorescence microscopy. Strong fluorescence was predominantly seen in the cytoplasm of untreated HT-29 and SW620 cells (Fig. 5) . Following treatment with AP (0.1 or 1 mg/ml, for 24 h), cytoplasmic fluorescence tended to decrease while nuclear fluorescence sharply increased, suggesting translocation of activated NF-κB protein from the cytoplasm to the nucleus.
Effect of APs on the binding of FITC-LPS in HT-29 and SW620 cells.
To evaluate the target sites of AP, FITC-LPS (10 µg/ml) was used to compete with AP in binding to the Toll-like receptor-4 (TLR4). The studies were performed with AP in the presence or absence of FITC-LPS in SW620 and HT-29 cells and assessed by flow cytometry. As the results demonstrate, preincubation of cells with AP (0.01, 0.1 or 1 mg/ml) resulted in a dose-dependent inhibition of LPS-FITC binding in CRC cells (Fig. 6) ; APs localized at the same position as TLR4 on the cell membrane. The data revealed a marked inhibitory effect of AP on FITC-LPS binding to TLR4 at 37˚C.
Discussion
Numerous studies have shown that consumption of fruits and vegetables can prevent cancer occurrence. As procyanidins and triterpenoids from apples have been shown to decrease CRC incidence (6), we examined the effects of APs on CRC apoptosis (an important anticarcinogenic process). A common approach for assessing proliferative activity involves measuring DNA content via BrdU incorporation into growing DNA strands (10, 11) . Results of BrdU immunocytochemistry, flow cytometry and western blotting showed that APs increased apoptosis in CRC cells in a dose-dependent manner, but had no effect on HIEC.
As the transcription factor NF-κB mediates cellular growth properties and apoptosis, we hypothesized that the NF-κB signaling pathway may be a target for AP; NF-κB is composed of homo-and heterodimers of the Rel family proteins, namely p65/RelA, p50/NF-κB1, p52/NF-κB2, c-Rel and cRel, which are sequestered in the cytoplasm by physical association with inhibitory proteins referred to as IκB (12, 13) . The bestcharacterized member of this family is I-κBα. Upon exposure to proinflammatory cytokines and microbial products, such as bacterial LPS, TNF-α and IL-1, I-κBα is rapidly phosphorylated by the IκB kinase (IKK) complex and degraded. This allows NF-κB to translocate to the nucleus, where it binds to regulatory elements within the promoter region of the target genes. Thus, the NF-κB signaling pathway plays a critical role in the regulation of the inflammatory response, the immune system, cellular proliferation, apoptosis, and antitumor effects of non-steroidal anti-inflammatory drugs (NSAIDs) in the colon (14) (15) (16) (17) (18) . When CRC cells were treated with APs (0.1 or 1 mg/ml) for 48 h, I-κBα levels were decreased in the cytoplasm, resulting in NF-κB nuclear translocation, according to western blot analyses (Fig. 4) . Immunofluorescence microscopy also monitored the translocation of activated NF-κB from the cytoplasm to the nucleus, but this technique remains primarily qualitative (Fig. 5) .
Activation of NF-κB is a double-edged sword (19, 20) , especially with regard to cancer. Whether NF-κB activation is beneficial or harmful for cancer remains controversial. Reportedly, NF-κB activation suppresses apoptosis (21) (22) (23) . However, increasing evidence shows that NF-κB transcription factors are involved in programmed cell death (24) (25) (26) (27) (28) . We initially observed that apoptotic responses in HT-29 and SW620 cells were partly attributable to modulation of the NF-κB signaling pathway by APs; effects of APs on I-κBα and p65 were investigated using western blotting and immunofluorescent techniques. From the experiments we concluded that AP-induced apoptosis is partly due to nuclear translocation of NF-κB.
We then assessed the targets of APs on CRC cells. We used LPS labeled with FITC (FITC-LPS) to compete with AP in binding to TLR4, because LPS is the main ligand of the TLR4. Using flow cytometry, we investigated the effect of APs on FITC-LPS binding in HT-29 and SW620 cells. We demonstrated the inhibitory effect of APs on FITC-LPS binding to TLR4 at 37˚C (Fig. 6) . LPs are toxic, proinflammatory constituents from potential pathogenic bacteria derived from intestinal flora imbalance; LPS-induced NF-κB signaling pathway activation plays an important role in the development of CRC from chronic bacterial infection (29) . Our results show that AP and LPS compete for the same position at the TLR4 on the cell membrane. When APs were combined with LPS, the NF-κB signaling pathway was suppressed, while AP alone slightly increased the expression of NF-κB and p65 nuclear proteins, and activated the NF-κB signaling pathway.
In conclusion, APs could induce apoptosis in human CRC cells, partly via the NF-κB pathway. While the anticarcinogenic activity of APs involves targeting the LPS/TLR4/ NF-κB pathway, identifying the precise target requires further research. Our data also show that APs have clinical implications for the prevention of colon cancer.
